Ramat Hasharon, Israel

Ofer Yossepowitch

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Mor Research Applications Ltd., Yeda Research and Develpment & Co. Ltd. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ofer Yossepowitch. Retrieved from https://idiyas.com/inventor/ofer-yossepowitch-3pbq1ea4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ofer Yossepowitch: Innovator in Cancer Diagnosis

Introduction

Ofer Yossepowitch is a notable inventor based in Ramat Hasharon, Israel. He has made significant contributions to the field of cancer diagnosis, particularly focusing on bladder and prostate cancers. His innovative approach utilizes non-invasive urinary tests to enhance diagnostic accuracy.

Latest Patents

Yossepowitch holds a patent for "Urinary biomarkers for cancer diagnosis." This invention is directed towards improving the diagnosis of bladder cancer and prostate cancer. It provides a simple, non-invasive method characterized by high sensitivity and specificity, utilizing urinary levels of heat shock proteins and anti-inflammatory cytokines as biomarkers.

Career Highlights

Throughout his career, Ofer Yossepowitch has worked with prominent organizations, including Yeda Research and Development Co. Ltd. and Mor Research Applications Ltd. His work has been instrumental in advancing cancer diagnostic techniques.

Collaborations

Yossepowitch has collaborated with esteemed colleagues such as Irun R Cohen and Meirav Pevsner-Fischer. These partnerships have contributed to the development and refinement of his innovative diagnostic methods.

Conclusion

Ofer Yossepowitch's contributions to cancer diagnosis through innovative urinary biomarkers represent a significant advancement in medical technology. His work continues to impact the field positively, offering hope for improved diagnostic methods in cancer care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…